l 694,458 has been researched along with tazobactam in 1 studies
| Studies (l 694,458) | Trials (l 694,458) | Recent Studies (post-2010) (l 694,458) | Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) |
|---|---|---|---|---|---|
| 29 | 0 | 10 | 1,327 | 153 | 694 |
| Protein | Taxonomy | l 694,458 (IC50) | tazobactam (IC50) |
|---|---|---|---|
| Beta-lactamase | Klebsiella pneumoniae | 0.08 | |
| Beta-lactamase | Escherichia coli | 0.01 | |
| Beta-lactamase | Citrobacter freundii | 0.096 | |
| Beta-lactamase | Citrobacter gillenii | 0.04 | |
| Beta-lactamase | Shouchella clausii | 0.004 | |
| Beta-lactamase | Burkholderia cenocepacia | 0.5 | |
| Beta-lactamase | Pseudomonas aeruginosa | 0.06 | |
| Beta-lactamase | Pseudomonas aeruginosa | 2 | |
| B2 bradykinin receptor | Cavia porcellus (domestic guinea pig) | 4.8 | |
| Beta-lactamase | Staphylococcus aureus | 0.5 | |
| Beta-lactamase | Bacillus licheniformis | 0.51 | |
| Beta-lactamase | Escherichia coli K-12 | 0.25 | |
| Beta-lactamase | Citrobacter freundii | 0.93 | |
| Beta-lactamase | Enterobacter cloacae | 1.3748 | |
| Beta-lactamase SHV-1 | Escherichia coli | 0.222 | |
| Beta-lactamase SHV-1 | Klebsiella pneumoniae | 0.11 | |
| Beta-lactamase OXA-1 | Escherichia coli | 4.8 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.83 | |
| Cytochrome P450 2B6 | Homo sapiens (human) | 0.11 | |
| Beta-lactamase | Pseudomonas aeruginosa PAO1 | 2.51 | |
| Beta-lactamase TEM | Escherichia coli | 0.0828 | |
| Beta-lactamase | Morganella morganii | 0.19 | |
| Beta-lactamase | Salmonella enterica subsp. enterica serovar Westhampton | 0.0022 | |
| Beta-lactamase | Pseudomonas aeruginosa | 2 | |
| Beta-lactamase | Enterobacter cloacae | 0.03 | |
| Class D beta-lactamase | Brachyspira pilosicoli | 0.16 | |
| Beta-lactamase | Pseudomonas luteola | 0.04 | |
| Beta-lactamase | Escherichia coli | 0.24 | |
| Beta-lactamase | Serratia fonticola | 6.9 | |
| Beta-lactamase | Enterobacter cloacae | 0.06 | |
| Beta-lactamase | Escherichia coli | 0.002 | |
| Carbapenem-hydrolyzing beta-lactamase KPC | Klebsiella pneumoniae | 0.372 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
1 other study(ies) available for l 694,458 and tazobactam
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |